A testosterone patch can provide a modest but meaningful improvement in postmenopausal libido for women not taking estrogen.
A testosterone patch can provide a modest but meaningful improvement in postmenopausal libido for women not taking estrogen, according to research published in the Nov. 6 issue of the New England Journal of Medicine.
Susan R. Davis, MD, PhD, of Monash University in Prahran, Australia, and colleagues conducted a double-blind, placebo-controlled trial of 814 women with low libido who were randomized to receive a patch delivering 150 or 300 µg a day of testosterone or placebo for a period of 52 weeks.
At week 24, the researchers measured the efficacy of the hormone and found that for the 300 µg testosterone group, there was an increase in the 4-week frequency of satisfying sexual episodes of 2.1 versus 1.2 for the 150-µg group and 0.7 for the placebo group. Women in both treatment groups reported increased desire and decreased distress, the study showed. However, women in the 300-µg treatment group had more androgenic adverse events, such as unwanted hair growth, the investigators found.
The research was supported by grants from Procter & Gamble Pharmaceuticals. Several of the study authors report financial relationships with the pharmaceutical industry.
Davis SR, Moreau M, Kroll R, et al.Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med. 2008;359:2005-2017.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More